Anthrasafe 20mg Injection

Anthrasafe 20mg Injection

Product Details:


Product Description

Anthrasafe 20mg Injection is indicated for treatment of Kaposi's sarcoma, lymphoma, and acute lymphocytic leukemia. Administered via intravenous route, it shows protein binding ability of about 75% with metabolism in liver. This medicinal formulation works by inhibiting progression of topoisomerase-II which is required for relaxation of supercoils in DNA. This activity of doxorubicin results in prevention of DNA replication which causes death of tumor cells. Offered Anthrasafe 20mg Injection has liposome as a vehicle of administration that helps in increasing effectiveness of the drug and delivering better results. 

Product details

Minimum Order Quantity

1 Vial

Packaging Type

Glass Bottle



Injection Site



* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Back to top
NEXT GEN BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.